Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
U kan zich nog vandaag via e-mail inschrijven om aanwezig te zijn.
Beste allen Zak massaal af 25/06 naar Brussel. Hou eveneens al een plekje vrij in de agenda 5 weken erna ook. Ik kan jullie alleen maar adviseren jullie goed voor te bereiden, de jaarrekeningen van 2016-2017 en 2018 te bestuderen en de nodige conclusies te trekken. Zet jullie vragen (financieel en operationeel) - hoe eenvoudig ze ook mogen lijken - op papier en vuur ze op een vriendelijke doch kordate manier af op management en raad van bestuur. FSMA geeft aan dat er onvoldoende duidelijkheid is om ook maar iets goed te keuren. Het is niet omdat je 'een kleine aandeelhouder' bent dat je ook 'klein in gedachten' hoeft te zijn en je je moet laten bestelen. Zie link: www.tijd.be/ondernemen/grondstoffen/f... Met hartelijke groeten en tot 25/06 !
Idd, indien u zich niet kunt begeven naar Brussel kun u nog tegenstemmen per brief of e-mail. Het is natuurlijk altijd beter aanwezig te zijn. Fijne groeten
Inderdaad ik kan me nog inschrijven voor de AVA. Moet je hiervoor een attest van je bank hebben dat je aandeelhouder bent? Het gaat om aandelen die op een effectenrekening staan. Ik vraag me af of het iets gaat uithalen? Verplaatsing naar Bxl en een dag verlof opofferen versus.....?
Blijkbaar heb ik nog een attest van mijn bank nodig.....
U print het document af, invullen en per direct sturen naar het e-mail adres. Beste groeten
Regulated Information Nyrstar: Recapitalisation steps commence: Launch of practice statement letter for Scheme of NN2 Newco Limited and entry into agreements regarding the sale of the operating group 20 June 2019 at 01:00am CEST Update on Restructuring – recapitalisation steps commence Nyrstar NV (“Nyrstar” or the “Company”, and, together with its subsidiaries (the “Operating Group”), the “Group”)) today provides an update on the Recapitalisation terms announced on 15 April 2019 and publishes certain key documents, including the practice statement letter and the report prepared by the independent directors by the Company in accordance with article 524 of the Belgian Company Code on its website. NN2 Newco Limited and NN1 Newco Limited incorporation and bond accessions Nyrstar informs the holders of the 5% convertible bonds due 2022 issued by Nyrstar NV on 11 July 2016 (ISIN: BE6288132101) (the Convertible Bonds) and the holders of the €340,000,000 8 ½% Senior Notes due 2019 and the €500,000,000 6.875% Senior Notes due 2024 issued by Nyrstar Netherlands (Holdings) B.V. (the High Yield Notes) that in accordance with the requisite bondholder consents received on 21 May 2019 (pursuant to two successful consent solicitations in relation to the High Yield Notes and at a convertible bondholder meeting in relation to the Convertible Bonds): (i) two third supplemental indentures have been entered into with respect to the High Yield Notes (1) effecting (a) the amendments sought in the consent solicitations, including the accession of NN2 Newco Limited as a co-issuer of the High Yield Notes, changing the governing law of the High Yield Notes to English law and providing for the submission to the jurisdiction of the courts of England and Wales and (b) the accession of NN1 Newco Limited as a guarantor of the High Yield Notes, in each case effective and operative as of the date hereof and (2) documenting the waivers sought in the consent solicitations, in each case effective and operative since 21 May 2019. The third supplemental indentures bind all holders of the High Yield Notes, including those that did not give their consent; and (ii) a supplemental trust deed has been entered into with respect to the Convertible Bonds, pursuant to which (1) the amendments sought at the convertible bondholder meeting have been effected (primarily in relation to a change to the jurisdiction provisions in the Convertible Bonds to make submission to the jurisdiction of the English courts reciprocal) and (2) NN2 Newco Limited has acceded as a co-obligor in respect of the Convertible Bonds, with a separate supplemental agency agreement having been entered into to document this. A deed of waiver has also been entered into in order to memorialise the waivers granted pursuant to the consent solicitations. Furthermore, in connection with the accession of NN1 Newco Limited as a guarantor under the High Yield Notes and in accordance with the terms of the Convertible Bonds, NN1 Newco Limited has also acceded as a guarantor under the Convertible Bonds through the execution of an amendment and restatement deed in respect of the existing guarantee. This follows the incorporation of NN2 Newco Limited and NN1 Newco Limited, two English subsidiaries of Nyrstar NV to implement the Recapitalisation. Practice Statement Letter - launch of Scheme Following the execution of the accessions and amendment documents described above, NN2 Newco Limited has published a practice statement letter in relation to a scheme of arrangement (under Part 26 of the Companies Act 2006) to be proposed by NN2 Newco Limited in respect of the High Yield Notes and the Convertible Bonds (the Scheme). The practice statement letter recounts the circumstances that led to the signing of the lock-up agreement and the recapitalisation terms, in accordance with the Company’s past press releases and its annual report. The holders of the High Yield Notes and Convertible Bonds are invited to view the terms of the Practice Statement Letter. A copy of the practice statement letter may be found on the Information Agent’s website: www.lucid-is.com/nyrstar , and further information may be requested from: Lucid Issuer Services Limited (as Information Agent for the Scheme) Tankerton Works 12 Argyle Walk London WC1H 8HA United Kingdom Tel: +44 20 7704 0880 Fax: +44 20 3004 1590 Attention: Thomas Choquet / Sunjeeve Patel / Victor Parzyjagla Email: nyrstar@lucid-is.com Website: www.lucid-is.com/nyrstar Further details of Nyrstar’s recapitalisation may be found here: www.nyrstar.com/en/investors/restruct... Report independent directors As previously announced the Company decided to apply voluntarily the procedure in article 524 of the Belgian Companies Code in relation to the proposed sale by the Company of the operating group to NN2 Newco Limited (a newly incorporated English company). The Company has today completed the procedure provided for in article 524 of the Belgian Companies Code. The report of the independent directors prepared in accordance with article 524, §2 of the Belgian Companies Code has been published on the above-referenced section dedicated to the Restructuring on the Company’s website (link). Following completion of the 524 procedure, various agreements have now been entered into relating to (i) the proposed sale of the operating group to NN2 Newco Limited, such transfer to be for a nominal amount of EUR 1 taking into account the fair market value of the assets transferred (as adjusted by liabilities within the operating group), (ii) to the proposed issue of 98% of the shares of NN2 Newco Limited to Trafigura and (iii) the Operating Group providing certain funding towards the continued operating costs of the Company following the Recapitalisation. We confirm that the general shareholders’ meeting of the Company will take place on 25 June 2019 and the Board of Directors will be available to respond to questions raised by shareholders.
Goeienacht DZR, Ik hoop uw cynische commentaren te kunnen horen op de AV van Nyrstar op 25 juni. U hebt toch, hoop ik, één aandeeltje gekocht voor 11 juni om er toch maar bij te kunnen zijn. Ongeveer 0.20 Euro kan toch niet té veel zijn om er bij te kunnen zijn. Zelfs voor een Hollander.... Ik kijk er naar uit om u te ontmoeten of minstens te horen. Den Blinker
Regulated Information – Inside Information Nyrstar provides an update relating to the 2019 annual general shareholders’ meeting and further impairment of the Myra Falls mine 22 June 2019 at 19:00 CEST Nyrstar NV ("Nyrstar" or the “Company” and, together with its subsidiaries, the “Group”) today announces that it is withdrawing resolutions relating to the financial statements for the financial year ended 31 December 2018 from the proposed agenda and resolutions of the annual general shareholders' meeting. The shareholders’ meeting remains scheduled to commence at 11:00 a.m. CEST on 25 June 2019 at BluePoint, A. Reyerslaan 80, 1030 Brussels, Belgium. The Company will schedule a further shareholders’ meeting to consider the financial statements as soon as its auditor has finished its audit. The Company notes that the financial statements for the financial year ended 31 December 2018, published on 26 May 2019, included an audit opinion issued in accordance with article 143, §2 of the Belgian Company Code (“non-compliance opinion”) on the basis that certain information requested from the Company was not timely delivered to its auditor. The Company is continuing to work hard with its auditor to deliver such information to the satisfaction of its auditor with the intention that the auditor will issue its audit opinion once it has received and audited all such information. Since the publication of the consolidated financial statements for the financial year ended 31 December 2018 on 26 May 2019, the Company has continued to update the life of mine plan for its Myra Falls mine in Canada. Changes to the mine plan resulted in lower recoverable amounts for the Myra Falls mine than previously expected. The Company has concluded that it is appropriate to recognise an additional impairment of EUR 30 million for Myra Falls in the 31 December 2018 consolidated financial statements of the Group and has discussed this with its auditor. Consequently, when the 2018 consolidated financial statements of the Group will be reissued, they will include a non-cash, pre-tax impairment loss of EUR 130 million. This impairment loss fully relates to pre-tax impairment losses on Nyrstar’s Mining assets (EUR 117.2 million) at Langlois and Myra Falls and specific asset write-offs in Metals Processing (EUR 11.4 million). The further impairment of Myra Falls has not been a factor in Nyrstar’s delay in re-issuing audited accounts for the financial year ended 31 December 2018. As communicated in the press release issued by the Company on 20 June 2019, announcing the commencement of the recapitalisation steps, it is noted that the Practice Statement Letter to Scheme Creditors and the Report by the Committee of Independent Directors in accordance with Article 524 of the Belgian Companies Code have been published on Nyrstar’s website at the following address: www.nyrstar.com/en/investors/restruct... The Company encourages its stakeholders (including its shareholders) to review these documents as they provide important information about the current situation and the background to it. The Company will continue to publish more information on that website to ensure that the stakeholders are kept informed about developments.
Den Blinker schreef op 20 juni 2019 02:18 :
Goeienacht DZR,
Ik hoop uw cynische commentaren te kunnen horen op de AV van Nyrstar op 25 juni.
U hebt toch, hoop ik, één aandeeltje gekocht voor 11 juni om er toch maar bij te kunnen zijn.
Ongeveer 0.20 Euro kan toch niet té veel zijn om er bij te kunnen zijn.
Zelfs voor een Hollander....
Ik kijk er naar uit om u te ontmoeten of minstens te horen.
Den Blinker
Hallo Den Blinker, ik heb helemaal niks te zoeken op deze vergadering, die heeeel lang en heeeel heet gaat worden. Ik wens je dus veel sterkte en succes...!!
Een afschijving van 130milj op de mijnen ,kstel me de vraag aan wie ze die ontginning gaan verkopen zonder in de boeken te worden opgenomen Trafigura moet gecontroleerd worden van kop tot teen
Alias321 schreef op 24 juni 2019 08:12 :
Een afschijving van 130milj op de mijnen ,kstel me de vraag aan wie ze die ontginning gaan verkopen zonder in de boeken te worden opgenomen
Trafigura moet gecontroleerd worden van kop tot teen
De aandeelhouders worden flink onder druk gezet.
Denk dat trafigura zwaar onder druk zal gezet worden.
Alias321 schreef op 24 juni 2019 08:25 :
Denk dat trafigura zwaar onder druk zal gezet worden.
Een olifant kan veel muggen verdragen.
Geen olifant ,maar ne vos ,die aan het uitsterven is.
Alias321 schreef op 24 juni 2019 09:04 :
Geen olifant ,maar ne vos ,die aan het uitsterven is.
Ik denk dat je in de war bent.
het koetje met gestolen geld zal gemolken worden
De Nyrstar-aandeelhouders hebben jarenlang zitten slapen en krijgen nu hun 'beloning' daarvoor.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee